“DEPO MEDROKSI PROGESTERON ASETAT (DMPA) INCREASES BODY MASS INDEX OF ACCEPTORS BUT DECREASES THEIR LIBIDO”. 2017. Proceedings of the International Conference on Applied Science and Health, no. 2 (September): 81-85. https://publications.inschool.id/index.php/icash/article/view/880.